Jolley Julie Diane 4

What Happened

• Julie Diane Jolley, Enhabit's Executive VP of Home Health Operations, had a mix of vested awards and outstanding shares converted and canceled under the company's merger. The filing shows acquisitions (vestings) of 129,409 shares (totaling $1,785,844) and dispositions to the issuer of 266,539 shares for $3,678,238 — all at the Merger Consideration of $13.80 per share. These entries reflect RSUs/PSUs vesting and being converted into the right to receive cash under the Merger Agreement, and the subsequent cancellation/repurchase by the issuer.

Key Details

• Transaction date: May 15, 2026; price: $13.80 per share (Merger Consideration).
• Dispositions to issuer: 266,539 shares for $3,678,238 total.
• Grant/acquisitions (vestings) shown: 129,409 shares valued at $1,785,844.
• Post-transaction holdings: shares and units were canceled and converted into cash at the Effective Time of the merger (no outstanding public common shares remain from these awards).
• Relevant footnotes: RSUs became fully vested and converted to cash (F2). 2024, 2025 and 2026 PSUs were vested/concluded at assumed performance levels (153.5%, 170%, 140%, respectively) and converted to the Merger Consideration (F3–F5). Cash payments were subject to applicable taxes and withholding.
• Filing timeliness: report filed with Form 4 dated May 15, 2026 (no late-filing indication in the provided data).

Context

• This is not a market purchase or opportunistic sale; it reflects the automatic conversion/cancellation of equity awards and shares under the Merger Agreement, with cash paid at the agreed $13.80 per share. Such entries are routine in merger transactions and do not, by themselves, signal a buy or sell decision by the insider.